Notably, prostate cancer is frequently characterized by CHD1 loss, which may explain why certain tumors are inherently permissive to VSV, while those with intact CHD1 or MAP3K7 exhibit resistance. The gene discussed is MAP3K7; the disease is prostate carcinoma.